172 related articles for article (PubMed ID: 37649039)
1. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
[TBL] [Abstract][Full Text] [Related]
2. Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women.
Løfling L; Støer NC; Nafisi S; Ursin G; Hofvind S; Botteri E
Eur J Epidemiol; 2023 Apr; 38(4):413-426. PubMed ID: 36877278
[TBL] [Abstract][Full Text] [Related]
3. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
4. Effects of Statin, Aspirin or Metformin Use on Recurrence-Free and Overall Survival in Patients with Biliary Tract Cancer.
McNamara MG; Aneja P; Le LW; Horgan AM; McKeever E; Knox JJ
Hepatogastroenterology; 2015 May; 62(139):564-9. PubMed ID: 26897929
[TBL] [Abstract][Full Text] [Related]
5. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway.
Støer NC; Bouche G; Pantziarka P; Sloan EK; Andreassen BK; Botteri E
Acta Oncol; 2021 Sep; 60(9):1146-1153. PubMed ID: 34338111
[TBL] [Abstract][Full Text] [Related]
6. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
[TBL] [Abstract][Full Text] [Related]
7. Low-dose aspirin use and survival in breast cancer patients: A nationwide cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LJ
Cancer Epidemiol; 2017 Apr; 47():20-27. PubMed ID: 28088656
[TBL] [Abstract][Full Text] [Related]
8. Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
Zanders MM; van Herk-Sukel MP; Vissers PA; Herings RM; Haak HR; van de Poll-Franse LV
Br J Cancer; 2015 Jul; 113(3):403-10. PubMed ID: 26180924
[TBL] [Abstract][Full Text] [Related]
9. Association of antidiabetic medication and statins with survival from ductal and lobular breast carcinoma in women with type 2 diabetes.
Hosio M; Urpilainen E; Hautakoski A; Marttila M; Arffman M; Sund R; Ahtikoski A; Puistola U; Läärä E; Karihtala P; Jukkola A
Sci Rep; 2021 May; 11(1):10445. PubMed ID: 34001921
[TBL] [Abstract][Full Text] [Related]
10. Population-wide impacts of aspirin, statins, and metformin use on prostate cancer incidence and mortality.
Koo HY; Jeong SM; Cho MH; Chun S; Shin DW; Park J
Sci Rep; 2021 Aug; 11(1):16171. PubMed ID: 34373584
[TBL] [Abstract][Full Text] [Related]
11. Statin use and breast cancer survival: a nationwide cohort study in Scotland.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
BMC Cancer; 2016 Aug; 16():600. PubMed ID: 27491389
[TBL] [Abstract][Full Text] [Related]
12. Association of antidiabetic medication and statins with breast cancer incidence in women with type 2 diabetes.
Hosio M; Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Puistola U; Läärä E; Jukkola A; Karihtala P
Breast Cancer Res Treat; 2019 Jun; 175(3):741-748. PubMed ID: 30895533
[TBL] [Abstract][Full Text] [Related]
13. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
[TBL] [Abstract][Full Text] [Related]
15. Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia.
Chang WT; Lin HW; Lin SH; Li YH
JAMA Netw Open; 2023 Apr; 6(4):e239515. PubMed ID: 37083661
[TBL] [Abstract][Full Text] [Related]
16. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
17. Statin Use, Cholesterol Level, and Mortality Among Females With Breast Cancer.
Murto MO; Simolin N; Arponen O; Siltari A; Artama M; Visvanathan K; Jukkola A; Murtola TJ
JAMA Netw Open; 2023 Nov; 6(11):e2343861. PubMed ID: 37976058
[TBL] [Abstract][Full Text] [Related]
18. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
[No Abstract] [Full Text] [Related]
19. Common medications and survival in women with ovarian cancer: A systematic review and meta-analysis.
Majidi A; Na R; Dixon-Suen S; Jordan SJ; Webb PM
Gynecol Oncol; 2020 Jun; 157(3):678-685. PubMed ID: 32317171
[TBL] [Abstract][Full Text] [Related]
20. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
